More in Pharmaceuticals
-
Biomed Analysis: Tackling drug-resistant malaria
Emerging resistance to artemisinin means efforts to track genetic markers and regulate the drug’s use must step up, says Priya Shetty. When parasites resistant to the anti-malarial drug artemisinin were discovered...
-
NGOs call for international regulation of synthetic biology
More than 100 non-governmental organisations (NGOs) have called for greater international oversight of the emerging science of synthetic biology – including a moratorium on the release and commercial use of...
-
Commitment to the MENA delivers results, with positive outlook for 2012
Hikma Pharmaceuticals PLC (LSE: HIK) (NASDAQ Dubai: HIK), the fast growing multinational pharmaceutical group, with sales in more than 40 countries across Europe, MENA and the USA, reports its preliminary results...
-
Omnicell to exhibit at Dubai International conference and exhibition
Omnicell will Demonstrate Recently Introduced G4 Medication Automation Platform. Omnicell, Inc., OMCL +0.89% a leading global provider of medication and supply management solutions and analytics software for healthcare facilities, will exhibit its state-of-the-art...
-
Nanotech offers more for health than nanodrugs
Nanotech in hygiene, fake drug detection and remote diagnosis will do more for health than nanodrugs, says Mohamed Abdel-Mottaleb. All countries should be planning for nanotechnology’s impact on healthcare, even...
-
Pharmaceuticals Sector
The Arab World’s healthcare sector needs to see considerable development in pharmaceuticals. The rapid growth of the pharmaceutical market in the region has presented the need to increase the quantity...
-
Healthcare Sector
The healthcare sector in The Arab World is showing signs of remarkable improvement as the quality of hospitals and the availability of qualified doctors has dramatically increased over the last...